Home » Topics » BioWorld Science

BioWorld Science
RSS

Theralase reports further phase Ib data on TLD-1433 in nonmuscle invasive bladder cancer

Feb. 5, 2019

Phase Ib data support expansion of indication for BioXcel's BXCL-501

Feb. 5, 2019

Pivotal ICARIA-MM study of isatuximab in relapsed/refractory multiple myeloma meets primary endpoint

Feb. 5, 2019

Guerbet identifies new compounds for liver cancer

Feb. 5, 2019

Neurotrope enters CRADA with NCI to study bryostatin-1 in leukemia and B-cell lymphoma

Feb. 5, 2019

Merck KGaA discloses new TLR7 and TLR8 antagonists

Feb. 5, 2019

Ideaya Biosciences presents aryl hydrocarbon receptor modulators

Feb. 5, 2019

High rate of response seen with Cytori Cell Therapy for perianal fistula in Crohn's disease

Feb. 5, 2019

SHCBP1 unveiled as therapeutic target in gastric cancer

Feb. 5, 2019

First patient enrolled in phase II study of tolperisone for acute muscle spasms

Feb. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...